FR2979825B1 - Phosphatidylcholines specifiques en tant que modulateurs de l'activite du facteur d'activation plaquettaire - Google Patents

Phosphatidylcholines specifiques en tant que modulateurs de l'activite du facteur d'activation plaquettaire

Info

Publication number
FR2979825B1
FR2979825B1 FR1158149A FR1158149A FR2979825B1 FR 2979825 B1 FR2979825 B1 FR 2979825B1 FR 1158149 A FR1158149 A FR 1158149A FR 1158149 A FR1158149 A FR 1158149A FR 2979825 B1 FR2979825 B1 FR 2979825B1
Authority
FR
France
Prior art keywords
activity
phosphatidylcholines
modulators
specific
platelet activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1158149A
Other languages
English (en)
Other versions
FR2979825A1 (fr
Inventor
Michel Lagarde
Evelyne Vericel
Madeleine Picq
Nathalie Bernoud-Hubac
Michel Guichardant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST NAT SCIENCES APPLIQ
Universite Claude Bernard Lyon 1 UCBL
Institut National de la Sante et de la Recherche Medicale INSERM
Institut National des Sciences Appliquees de Lyon
Original Assignee
INST NAT SCIENCES APPLIQ
Universite Claude Bernard Lyon 1 UCBL
Institut National de la Sante et de la Recherche Medicale INSERM
Institut National des Sciences Appliquees de Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST NAT SCIENCES APPLIQ, Universite Claude Bernard Lyon 1 UCBL, Institut National de la Sante et de la Recherche Medicale INSERM, Institut National des Sciences Appliquees de Lyon filed Critical INST NAT SCIENCES APPLIQ
Priority to FR1158149A priority Critical patent/FR2979825B1/fr
Priority to PCT/EP2012/067898 priority patent/WO2013037862A1/fr
Publication of FR2979825A1 publication Critical patent/FR2979825A1/fr
Application granted granted Critical
Publication of FR2979825B1 publication Critical patent/FR2979825B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1158149A 2011-09-13 2011-09-13 Phosphatidylcholines specifiques en tant que modulateurs de l'activite du facteur d'activation plaquettaire Active FR2979825B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1158149A FR2979825B1 (fr) 2011-09-13 2011-09-13 Phosphatidylcholines specifiques en tant que modulateurs de l'activite du facteur d'activation plaquettaire
PCT/EP2012/067898 WO2013037862A1 (fr) 2011-09-13 2012-09-13 Phosphatidylcholines spécifiques en tant que modulateurs de l'activité du facteur d'activation plaquettaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1158149A FR2979825B1 (fr) 2011-09-13 2011-09-13 Phosphatidylcholines specifiques en tant que modulateurs de l'activite du facteur d'activation plaquettaire

Publications (2)

Publication Number Publication Date
FR2979825A1 FR2979825A1 (fr) 2013-03-15
FR2979825B1 true FR2979825B1 (fr) 2013-11-29

Family

ID=46829788

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1158149A Active FR2979825B1 (fr) 2011-09-13 2011-09-13 Phosphatidylcholines specifiques en tant que modulateurs de l'activite du facteur d'activation plaquettaire

Country Status (2)

Country Link
FR (1) FR2979825B1 (fr)
WO (1) WO2013037862A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3063645B1 (fr) * 2017-03-08 2021-06-11 Lipther Acefapc pour le traitement des maladies acetylcholine dependantes
JP6664638B1 (ja) 2018-04-27 2020-03-13 株式会社 レオロジー機能食品研究所 新規プラズマローゲン誘導体
EP4438610A1 (fr) 2021-11-22 2024-10-02 Institute of Rheological Function of Food Co., Ltd. Composé, racémate dudit composé, sel dudit composé ou dudit racémate, composition, agent anti-inflammatoire, agent thérapeutique pour la démence et agent thérapeutique pour le syndrome de rett

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698269B1 (fr) 1992-11-24 1995-01-06 Inst Nat Sante Rech Med Nouveaux médicaments à base d'acides gras insaturés, utilisables notamment comme antiagrégants plaquettaires et/ou comme transporteurs privilégiés vers le cerveau.
EP2089400B1 (fr) * 2006-11-14 2016-01-27 Institut National des Sciences Appliquées de Lyon Procede de preparation d'acetyl, docosahexaenoyl-glycérophosphocholine, et son utilisation pour l'apport d'acides gras polyinsatures

Also Published As

Publication number Publication date
FR2979825A1 (fr) 2013-03-15
WO2013037862A1 (fr) 2013-03-21

Similar Documents

Publication Publication Date Title
PH12017501306A1 (en) Inhibitors of histone demethylases
EA201590200A1 (ru) Модуляторы пути активации комплемента и их применение
CL2014001762A1 (es) Compuestos derivados de benzaldehidos sustituidos, moduladores alostericos de hemoglobina; composicion farmaceutica que los comprende; y metodo para tratar una afeccion asociada con deficiencia de oxigeno tal como cancer, trastorno pulmonar, apoplejia, ulcera, enfermedad de alzheimer, entre otras.
BR112015001613A2 (pt) compostos que são agentes de modulação de s1p e/ou agentes de modulação de atx
EA201590118A1 (ru) Производные пирролидина и их применение в качестве модуляторов пути активации комплемента
EA201590053A1 (ru) Модуляторы пути системы комплемента и их применение
BR112015022417A2 (pt) métodos e composições para inibição de proteínas contendo bromodomínio
BR112012027034A2 (pt) inibidores da arginase e suas aplicações terapêuticas
EA029089B9 (ru) Модуляторы метил-модифицирующих ферментов, композиции и их применение
IN2014DN06501A (fr)
BR112015008487A2 (pt) compostos de benzeno substituído
EA201692506A2 (ru) Ингибиторы репликации вирусов гриппа
ECSP088854A (es) Moduladores bencimidazolicos de vr1
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
BR112014001600A2 (pt) composto inibidor do trajeto de sinalização notch
BR112012028451A2 (pt) composição tópica de iodopovidona
MX2013009764A (es) Moduladores de receptores canabinoides.
BR112015010791A2 (pt) moduladores de gpr40 de di-hidropirazol
UA113538C2 (xx) Фторметил-5,6-дигідро-4h-$1,3]оксазини
CL2013001482A1 (es) Compuestos derivados de 3-metil-7-oxo-4-tia-1-aza-biciclo[3.2.0]heptano para utilizarse en la inhibicion de beta-lactamasas producidas por bacterias y restaurar/potenciar la actividad de antibioticos; y composicion farmaceutica que los comprende.
TR201902057T4 (tr) Tetrasiklin bileşikleri.
GT201400242A (es) "nuevos compuestos de pirazol"
BR112015023878A2 (pt) composto, composição farmacêutica, e, uso de um composto
UY33568A (es) Compuestos que interactuan con proteina reguladora de glucocinasa para el tratamiento de diabetes.
EA201791321A1 (ru) Составы ингибитора lfa-1

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14